MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866. - Wikidata - wikimedia - TriplyDB

MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866.

MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866.

http://www.wikidata.org/entity/Q37691630

about

Epigenetic regulation of Runx2 transcription and osteoblast differentiation by nicotinamide phosphoribosyltransferase Clickable prodrugs bearing potent and hydrolytically cleavable nicotinamide phosphoribosyltransferase inhibitors.

P2860

Q38762650-1F920E0C-B1D5-43F1-B4B5-F5C781127E78 Q55029401-D12A885D-05F5-4824-B65A-6D9B174870DD

P2860

MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866.

http://www.wikidata.org/entity/Q37691630

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MC-PPEA as a new and more pote ...... onary inflammation than FK866.

@en

MC-PPEA as a new and more pote ...... onary inflammation than FK866.

@nl

type

label

MC-PPEA as a new and more pote ...... onary inflammation than FK866.

@en

MC-PPEA as a new and more pote ...... onary inflammation than FK866.

@nl

prefLabel

MC-PPEA as a new and more pote ...... onary inflammation than FK866.

@en

MC-PPEA as a new and more pote ...... onary inflammation than FK866.

@nl

P1433

Q37691630-F3D52A68-1353-42F5-9C1B-6A098D527A15

P1476

Q37691630-7437A2D3-5349-4A97-A7B7-F8C966C040A2

P2093

Q37691630-1F45852B-D476-4723-8A1B-73B07FBB0504

Q37691630-25729CF9-8C67-4B1C-862E-6EA738CF6EFA

Q37691630-2F802B32-2B20-4230-B6F7-AAEC510FD543

Q37691630-902D2E5B-9998-4384-AE24-6D232B38FA83

Q37691630-94446945-CD1E-4775-9033-5A9A337C4BCB

Q37691630-C5842B19-EC7B-4F69-AFDE-3B18328BD01A

P2860

Q37691630-008F4A1F-7D63-4589-8EA2-93098B6737D5

Q37691630-0856BF23-04A7-4D34-8043-431B9051B3EA

Q37691630-12A91AAB-B2F8-4DE8-A83A-3DB5DE0F908F

Q37691630-1CA5EF42-11F6-4E62-9804-40E26CF321AB

Q37691630-1FDB9119-E9C1-4054-8625-90E0E257F5DB

Q37691630-22DB860C-616B-41A8-9D39-7666623D1069

Q37691630-25FDC9F3-285F-4D1C-8427-D4E121A3CADD

Q37691630-2632BFB3-F0FE-4A58-833D-DB27A8ED9E3C

Q37691630-3550A4B0-F70B-43A0-B36C-EB948F655A3D

Q37691630-3D5ABBA8-4E18-4B15-A316-AC6468CACDD3

P304

Q37691630-1D455968-0845-45B6-8749-DFEFCE8A363E

P31

Q37691630-87AAC61A-0BA3-43E2-B77C-0CF767B561F7

P356

Q37691630-76125C82-3076-4A1E-9C5A-E399D8F97160

P407

Q37691630-3F3CDDCA-1AE7-49E7-97CD-78913973A06F

P478

Q37691630-C1A3F421-DD8F-4080-B061-C5964EC7D241

P50

Q37691630-B7E0AA36-AE50-4F51-BB0D-F3E2ACD83EB7

P577

Q37691630-2F091933-791F-40EE-A037-F2F305FED378

P698

Q37691630-B9897A38-A516-409D-8124-E06ECADD03E8

P921

Q37691630-73E096A0-68EB-449E-8928-D440C1634DC6

Q37691630-A12FA006-A5D1-4D61-AECF-05238CA609B1

P932

Q37691630-5FA5DE8E-47CF-4F1E-909F-60AA887362BD

P356

P1433

Drug Design, Development and Therapy

P1476

MC-PPEA as a new and more pote ...... monary inflammation than FK866

@en

P2093

Daniel P Heruth

http://www.w3.org/2001/XMLSchema#string

Dev Maulik

http://www.w3.org/2001/XMLSchema#string

Li Q Zhang

http://www.w3.org/2001/XMLSchema#string

Mark W Lee

http://www.w3.org/2001/XMLSchema#string

Peixin Huang

http://www.w3.org/2001/XMLSchema#string

Shui Qing Ye

http://www.w3.org/2001/XMLSchema#string

P2860

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli

Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation

The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells

The epidemiology of sepsis in the United States from 1979 through 2000

Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis.

Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.

Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD

The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor.

P304

629-641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S125349

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Keivan Sadrerafi

P577

2017-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28424540

http://www.w3.org/2001/XMLSchema#string

P921

P932

5344436

http://www.w3.org/2001/XMLSchema#string